U.S. charges Teva in generic drugs price-fixing probe

CNBC

The U.S. Justice Department charged Teva Pharmaceutical on Tuesday with conspiring with competitors to raise prices for generic drugs.

The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used pharmaceuticals, including a high cholesterol drug. read more »

Omni Healthcare accuses Health First of fraud in lawsuit; US and Florida decline to join

FLORIDA TODAY

Omni Healthcare is suing Health First, alleging the health care company gave doctors illegal incentives to refer patients to Health First facilities instead of other health care providers.

Omni filed a revised qui tam complaint Sunday in the U.S. Middle District Court of Florida.

A qui tam lawsuit is a lawsuit by which a whistleblower can bring fraud charges on behalf of the government and potentially receive a portion of the damages recovered. read more »

Ex-pharmaceutical company boss faces insider trading charges

AP NEWS

Sepehr Sarshar, 53, of Encinitas, California, was charged in Manhattan federal court with securities fraud, wire fraud and fraud in connection with a tender offer. He was released on $1 million bail after an initial appearance in San Diego federal court.

Authorities said he provided inside information in 2015 about a pending $3.2 billion buyout offer from Israel-based Teva Pharmaceutical Industries Limited, a generic drug giant, to his friends and family so they could trade securities in Auspex Pharmaceuticals, a company he founded. read more »